HARROW HEALTH, INC. License Agreements
10 Contracts & Agreements
- Third Amendment to License and Supply Agreement dated February 6, 2024 between Harrow IP, LLC and Sintetica S.A (Filed With SEC on March 19, 2024)
- Second Amendment to License and Supply Agreement, dated August 4, 2023, between Harrow IP, LLC and Sintetica S.A (Filed With SEC on November 13, 2023)
- License Agreement, dated as of August 18, 2021, by and between the Company and Wakamoto Pharmaceutical Co., Ltd (Filed With SEC on November 9, 2021)
- License and Supply Agreement, dated as of July 25, 2021, by and between the Company and Sintetica, S.A (Filed With SEC on August 10, 2021)
- License Agreement, dated July 29, 2019, among Stowe Pharmaceuticals, Inc., TGV-Health, LLC and TGV-Ophthalnix, LLC (Filed With SEC on November 13, 2019)
- License Agreement, dated July 28, 2019, among Mayfield Pharmaceuticals, Inc., TGV-Health, LLC and TGV-Gyneconix, LLC (Filed With SEC on November 13, 2019)
- Amended and Restated License Agreement dated April 10, 2018 between Imprimis Pharmaceuticals, Inc. and Richard L. Lindstrom, M.D (Filed With SEC on August 6, 2018)
- ASSETPURCHASE AND LICENSE AGREEMENT (Filed With SEC on June 20, 2017)
- ASSETPURCHASE AND LICENSE AGREEMENT (Filed With SEC on June 20, 2017)
- License Agreement, dated as of August 30, 2012, by and between Imprimis Pharmaceuticals, Inc. and Professional Compounding Centers of America, Inc (Filed With SEC on August 31, 2012)
